Retail Therapy, MB - financials and debts

Company age: 3 y. 2 mo.

Update

Retail Therapy - Company finances

EUR
2023
From: 2023-07-18
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 81,943 36,347 276,507
Profit before tax 11,918 16,881 48,302
Net profit 11,918 16,037 45,404
Equity 12,018 28,055 73,460
Liabilities 5,142 8,332 3,326
Non-current assets 0 0 0
Current assets 17,160 36,387 76,786
Total assets 17,160 36,387 76,786
Taxes paid
STI taxes - - 7,409
Financial indicators
Revenue change y/y - -55.6% +660.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 69.5% 44.1% 59.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 99.2% 57.2% 61.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 14.5% 44.1% 16.4%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 14.5% 46.4% 17.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.4 0.3 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Retail Therapy - Social security debts

The company had no debts to Sodra

Retail Therapy - VMI tax arrears

From To Overdue, €
2025-07-01 2025-07-20 1.61
2025-06-24 2025-06-30 0.69
2025-06-20 2025-06-23 845.65
2025-06-19 2025-06-19 844.96
2025-06-05 2025-06-18 0.96
2025-06-02 2025-06-04 73.89
2025-05-31 2025-06-01 73.08
2025-05-28 2025-05-30 119.57
2025-05-24 2025-05-27 3348.15
2025-05-20 2025-05-23 6732.48
2025-05-19 2025-05-19 6732.48
2025-05-17 2025-05-18 6732.48
2025-05-13 2025-05-16 6732.48
2025-05-12 2025-05-12 6732.48
2025-05-08 2025-05-11 6732.48
2025-05-07 2025-05-07 6732.48
2025-05-06 2025-05-06 6732.48
2025-05-05 2025-05-05 6732.48
2025-05-03 2025-05-04 6732.48
2025-05-01 2025-05-02 6700.98
2025-04-30 2025-04-30 6700.98
2025-04-28 2025-04-29 6700.98
2025-04-27 2025-04-27 3357.85
2025-04-25 2025-04-26 3357.85
2025-04-24 2025-04-24 3357.85
2025-04-22 2025-04-23 3357.85
2025-04-20 2025-04-21 3357.85
2025-04-18 2025-04-19 3357.85
2025-04-17 2025-04-17 3357.85
2025-04-16 2025-04-16 3357.85
2025-04-14 2025-04-15 3357.85
2025-04-11 2025-04-13 3357.85
2025-04-10 2025-04-10 3357.85
2025-04-09 2025-04-09 3357.85
2025-04-08 2025-04-08 3357.85
2025-04-07 2025-04-07 3357.85
2025-04-06 2025-04-06 3357.85
2025-04-04 2025-04-05 3357.85
2025-04-03 2025-04-03 3357.85
2025-04-02 2025-04-02 3352.45
2025-03-31 2025-04-01 3352.45
2025-03-30 2025-03-30 3352.45
2025-03-27 2025-03-29 3.29
2025-03-26 2025-03-26 3.29
2025-03-24 2025-03-25 14.26
2025-03-22 2025-03-23 14.26
2025-03-20 2025-03-21 14.26
2025-03-19 2025-03-19 14.26
2025-03-17 2025-03-18 14.26
2025-03-16 2025-03-16 14.26
2025-03-15 2025-03-15 14.26
2025-03-12 2025-03-14 118.26
2025-03-11 2025-03-11 118.26
2025-03-10 2025-03-10 118.26
2025-03-09 2025-03-09 118.26
2025-03-07 2025-03-08 118.23
2025-03-06 2025-03-06 107.29
2025-03-05 2025-03-05 3.29
2025-03-04 2025-03-04 3.29
2025-03-03 2025-03-03 3.29
2025-03-02 2025-03-02 3.29
2025-03-01 2025-03-01 3.29
2025-02-28 2025-02-28 3.29
2025-02-27 2025-02-27 0.0
2025-02-26 2025-02-26 0.0
2025-02-25 2025-02-25 819.71
2025-02-20 2025-02-24 7491.71
2025-02-19 2025-02-19 6672.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Retail Therapy, MB (code 306361277) is a Small partnership engaged in other non-specialised retail sale. In 2025, the company generated revenue of €276.5K and net profit of €45.4K, with a profit margin of 16.4%. Revenue increased sharply from €36.3K in 2024 and €81.9K in 2023, showing a strong two-year expansion in turnover. Net profit also improved over the period, from €11.9K in 2023 to €16.0K in 2024 and €45.4K in 2025, although the margin was highest in 2024. At the end of 2025, total assets reached €76.8K, equity stood at €73.5K, and liabilities were limited to €3.3K, indicating a very strong equity base. The latest ratios reflect efficient use of capital, with ROE at 61.8%, ROA at 59.1%, debt-to-equity at 0.05, and asset turnover of 3.60x. The business therefore combined rapid revenue growth with a solid balance sheet in 2025.